TAFA4 and endocervical adenocarcinoma: The methylation testing of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (CESC)’s FAM19A4 and hsa-miR124-2 was conducted using the MethHC version 2.0 platform, released in 2021, which has counted 27,190 DNA methylation data points, 1732 expression data points, and 11,196 microRNA data points in 33 different types of tumors.